The Latest Breaking News from CTAs

Despite recent signs of moderation in inflation, the better-than-expected January jobs data could force the Fed to raise interest rates even further. This is expected to keep the stock market highly volatile in the near term. Given a volatile market backdrop, investing in high-quality stocks AbbVie (ABBV), Cintas (CTAS), and…

Clear indication by the Fed on the continuation of interest rate hikes in the foreseeable future has nipped the recent market optimism in the bud. With growth forecasts in jeopardy, it may be opportune to prioritize income generation with Cintas (CTAS), as it pays reliable dividends. Read on….

Cintas (NASDAQ:CTAS) has outperformed the market over the past 15 years by 9.68% on an annualized basis producing an average annual return of 16.14%. Currently, Cintas has a market capitalization of $38.79 billion.

Cintas (NASDAQ:CTAS) has outperformed the market over the past 5 years by 14.57% on an annualized basis producing an average annual return of 25.74%. Currently, Cintas has a market capitalization of $40.73 billion.

The stock market is experiencing heightened volatility and given the Fed’s aggressive monetary stance to tame inflation, stocks might tumble further in price before hitting a bottom. Hence, we think dividend aristocrats W.W. Grainger (GWW), Target Corp. (TGT), and Cintas Corp. (CTAS) could be quality additions to one’s portfolio now.…

Industrial production and capacity utilization have increased significantly in the first quarter of this year, as per the Federal Reserve’s recent report. Also, planned infrastructure spending is expected to boost industrial activities and create new opportunities in the industrial market. Given this backdrop, we think the shares of industrial stocks…

Deepening logistical disruptions caused by the Russia-Ukraine war, record-high inflation, and high oil prices have dampened investor sentiment. Furthermore, many economists expect the economy to succumb to a recession, with inflation hitting a fresh 40-year high and oil prices soaring. Therefore, we think it could be wise to bet on…

Cintas Corp's (NASDAQ:CTAS) price target was raised to $493 from $460 by Goldman Sachs analyst George Tong while maintaining the Buy rating on the shares. Tong predicts continued strength from the healthcare sector that is increasingly adopting uniform rental programs at Cintas post-COVID due to cost and hygiene benefits. Related: Cintas' Q3 Results Beat Estimates, Clocks…

Cintas Corp (NASDAQ:CTAS) reported third-quarter revenue growth of 10.3% year-over-year to $1.96 billion and +10% on an organic basis, beating the consensus of $1.91 billion. Adjusted EPS was $2.69 for the quarter, which beat the consensus of $2.43. The operating income increased 24.9% Y/Y to $407.61 million, and the margin expanded by 242…